EXPONENT INC (EXPO) Stock Fundamental Analysis

NASDAQ:EXPO • US30214U1025

71.85 USD
+0.13 (+0.18%)
Last: Feb 12, 2026, 02:46 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

6

EXPO gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 89 industry peers in the Professional Services industry. Both the health and profitability get an excellent rating, making EXPO a very profitable company, without any liquidiy or solvency issues. EXPO is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year EXPO was profitable.
  • In the past year EXPO had a positive cash flow from operations.
  • EXPO had positive earnings in each of the past 5 years.
  • EXPO had a positive operating cash flow in 4 of the past 5 years.
EXPO Yearly Net Income VS EBIT VS OCF VS FCFEXPO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M

1.2 Ratios

  • With an excellent Return On Assets value of 13.77%, EXPO belongs to the best of the industry, outperforming 91.01% of the companies in the same industry.
  • The Return On Equity of EXPO (26.02%) is better than 79.78% of its industry peers.
  • EXPO has a better Return On Invested Capital (14.18%) than 80.90% of its industry peers.
Industry RankSector Rank
ROA 13.77%
ROE 26.02%
ROIC 14.18%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EXPO Yearly ROA, ROE, ROICEXPO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • EXPO has a Profit Margin of 18.35%. This is amongst the best in the industry. EXPO outperforms 86.52% of its industry peers.
  • In the last couple of years the Profit Margin of EXPO has declined.
  • EXPO's Operating Margin of 20.64% is amongst the best of the industry. EXPO outperforms 87.64% of its industry peers.
  • EXPO's Operating Margin has been stable in the last couple of years.
  • The Gross Margin of EXPO (92.96%) is better than 100.00% of its industry peers.
  • In the last couple of years the Gross Margin of EXPO has remained more or less at the same level.
Industry RankSector Rank
OM 20.64%
PM (TTM) 18.35%
GM 92.96%
OM growth 3Y-9.14%
OM growth 5Y-0.23%
PM growth 3Y-2.97%
PM growth 5Y-2.47%
GM growth 3Y0.68%
GM growth 5Y-0.51%
EXPO Yearly Profit, Operating, Gross MarginsEXPO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), EXPO is creating some value.
  • EXPO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
EXPO Yearly Shares OutstandingEXPO Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
EXPO Yearly Total Debt VS Total AssetsEXPO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

  • EXPO has an Altman-Z score of 8.87. This indicates that EXPO is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of EXPO (8.87) is better than 96.63% of its industry peers.
  • There is no outstanding debt for EXPO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 8.87
ROIC/WACC1.61
WACC8.8%
EXPO Yearly LT Debt VS Equity VS FCFEXPO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.3 Liquidity

  • A Current Ratio of 2.69 indicates that EXPO has no problem at all paying its short term obligations.
  • EXPO has a better Current ratio (2.69) than 86.52% of its industry peers.
  • A Quick Ratio of 2.69 indicates that EXPO has no problem at all paying its short term obligations.
  • With an excellent Quick ratio value of 2.69, EXPO belongs to the best of the industry, outperforming 86.52% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.69
Quick Ratio 2.69
EXPO Yearly Current Assets VS Current LiabilitesEXPO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • EXPO shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -1.89%.
  • Measured over the past 5 years, EXPO shows a small growth in Earnings Per Share. The EPS has been growing by 6.06% on average per year.
  • Looking at the last year, EXPO shows a small growth in Revenue. The Revenue has grown by 4.21% in the last year.
  • Measured over the past years, EXPO shows a small growth in Revenue. The Revenue has been growing by 7.79% on average per year.
EPS 1Y (TTM)-1.89%
EPS 3Y2%
EPS 5Y6.06%
EPS Q2Q%6.52%
Revenue 1Y (TTM)4.21%
Revenue growth 3Y4.28%
Revenue growth 5Y7.79%
Sales Q2Q%4.54%

3.2 Future

  • Based on estimates for the next years, EXPO will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.35% on average per year.
  • The Revenue is expected to grow by 7.39% on average over the next years.
EPS Next Y10.21%
EPS Next 2Y9.98%
EPS Next 3Y9.35%
EPS Next 5YN/A
Revenue Next Year10.24%
Revenue Next 2Y9.35%
Revenue Next 3Y7.39%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
EXPO Yearly Revenue VS EstimatesEXPO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M
EXPO Yearly EPS VS EstimatesEXPO Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5 2 2.5

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • EXPO is valuated quite expensively with a Price/Earnings ratio of 34.54.
  • EXPO's Price/Earnings ratio is in line with the industry average.
  • EXPO's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 28.18.
  • With a Price/Forward Earnings ratio of 31.34, EXPO can be considered very expensive at the moment.
  • EXPO's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. EXPO is more expensive than 60.67% of the companies in the same industry.
  • EXPO is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 28.01, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 34.54
Fwd PE 31.34
EXPO Price Earnings VS Forward Price EarningsEXPO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, EXPO is valued a bit more expensive than 60.67% of the companies in the same industry.
  • EXPO's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 29.17
EV/EBITDA 26.35
EXPO Per share dataEXPO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • EXPO has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)3.38
PEG (5Y)5.7
EPS Next 2Y9.98%
EPS Next 3Y9.35%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 1.63%, EXPO has a reasonable but not impressive dividend return.
  • EXPO's Dividend Yield is a higher than the industry average which is at 1.44.
  • EXPO's Dividend Yield is comparable with the S&P500 average which is at 1.80.
Industry RankSector Rank
Dividend Yield 1.63%

5.2 History

  • EXPO has paid a dividend for at least 10 years, which is a reliable track record.
  • EXPO has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years11
Div Non Decr Years11
EXPO Yearly Dividends per shareEXPO Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • 58.07% of the earnings are spent on dividend by EXPO. This is a bit on the high side, but may be sustainable.
DP58.07%
EPS Next 2Y9.98%
EPS Next 3Y9.35%
EXPO Yearly Income VS Free CF VS DividendEXPO Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
EXPO Dividend Payout.EXPO Dividend Payout, showing the Payout Ratio.EXPO Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

EXPONENT INC

NASDAQ:EXPO (2/12/2026, 2:46:41 PM)

71.85

+0.13 (+0.18%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)02-05
Earnings (Next)04-29
Inst Owners97.74%
Inst Owner Change-1.06%
Ins Owners0.97%
Ins Owner Change0.98%
Market Cap3.58B
Revenue(TTM)582.01M
Net Income(TTM)104.84M
Analysts82
Price Target87.21 (21.38%)
Short Float %5.02%
Short Ratio6.33
Dividend
Industry RankSector Rank
Dividend Yield 1.63%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP58.07%
Div Incr Years11
Div Non Decr Years11
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.88%
Min EPS beat(2)3.34%
Max EPS beat(2)6.42%
EPS beat(4)4
Avg EPS beat(4)6.95%
Min EPS beat(4)3.34%
Max EPS beat(4)11.81%
EPS beat(8)7
Avg EPS beat(8)7.03%
EPS beat(12)8
Avg EPS beat(12)4.77%
EPS beat(16)12
Avg EPS beat(16)5.48%
Revenue beat(2)1
Avg Revenue beat(2)0.83%
Min Revenue beat(2)-0.43%
Max Revenue beat(2)2.1%
Revenue beat(4)3
Avg Revenue beat(4)0.77%
Min Revenue beat(4)-0.43%
Max Revenue beat(4)2.1%
Revenue beat(8)4
Avg Revenue beat(8)0.05%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-2.84%
EPS NQ rev (1m)-0.18%
EPS NQ rev (3m)-0.18%
EPS NY rev (1m)-0.08%
EPS NY rev (3m)-0.08%
Revenue NQ rev (1m)2.1%
Revenue NQ rev (3m)2.1%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.03%
Valuation
Industry RankSector Rank
PE 34.54
Fwd PE 31.34
P/S 6.27
P/FCF 29.17
P/OCF 27.11
P/B 8.9
P/tB 9.09
EV/EBITDA 26.35
EPS(TTM)2.08
EY2.89%
EPS(NY)2.29
Fwd EY3.19%
FCF(TTM)2.46
FCFY3.43%
OCF(TTM)2.65
OCFY3.69%
SpS11.45
BVpS8.07
TBVpS7.9
PEG (NY)3.38
PEG (5Y)5.7
Graham Number19.44
Profitability
Industry RankSector Rank
ROA 13.77%
ROE 26.02%
ROCE 19.43%
ROIC 14.18%
ROICexc 21.54%
ROICexgc 22.02%
OM 20.64%
PM (TTM) 18.35%
GM 92.96%
FCFM 21.51%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-9.14%
OM growth 5Y-0.23%
PM growth 3Y-2.97%
PM growth 5Y-2.47%
GM growth 3Y0.68%
GM growth 5Y-0.51%
F-Score7
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 92.68%
Cap/Sales 1.63%
Interest Coverage 250
Cash Conversion 103.34%
Profit Quality 117.23%
Current Ratio 2.69
Quick Ratio 2.69
Altman-Z 8.87
F-Score7
WACC8.8%
ROIC/WACC1.61
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1.89%
EPS 3Y2%
EPS 5Y6.06%
EPS Q2Q%6.52%
EPS Next Y10.21%
EPS Next 2Y9.98%
EPS Next 3Y9.35%
EPS Next 5YN/A
Revenue 1Y (TTM)4.21%
Revenue growth 3Y4.28%
Revenue growth 5Y7.79%
Sales Q2Q%4.54%
Revenue Next Year10.24%
Revenue Next 2Y9.35%
Revenue Next 3Y7.39%
Revenue Next 5YN/A
EBIT growth 1Y6.51%
EBIT growth 3Y-5.25%
EBIT growth 5Y7.55%
EBIT Next Year31.95%
EBIT Next 3Y16.05%
EBIT Next 5YN/A
FCF growth 1Y-19.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-17.27%
OCF growth 3YN/A
OCF growth 5YN/A

EXPONENT INC / EXPO FAQ

What is the fundamental rating for EXPO stock?

ChartMill assigns a fundamental rating of 6 / 10 to EXPO.


What is the valuation status of EXPONENT INC (EXPO) stock?

ChartMill assigns a valuation rating of 2 / 10 to EXPONENT INC (EXPO). This can be considered as Overvalued.


Can you provide the profitability details for EXPONENT INC?

EXPONENT INC (EXPO) has a profitability rating of 7 / 10.


What is the valuation of EXPONENT INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for EXPONENT INC (EXPO) is 34.54 and the Price/Book (PB) ratio is 8.9.


How sustainable is the dividend of EXPONENT INC (EXPO) stock?

The dividend rating of EXPONENT INC (EXPO) is 5 / 10 and the dividend payout ratio is 58.07%.